Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
about
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer.Increasing utilization and predictors of hematopoietic growth factors in patients diagnosed with colorectal cancer: findings from a large national population-based cohort in the USA, 1992-2009.A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study.
P2860
Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Colony-stimulating factor use ...... o were receiving chemotherapy.
@en
type
label
Colony-stimulating factor use ...... o were receiving chemotherapy.
@en
prefLabel
Colony-stimulating factor use ...... o were receiving chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
Colony-stimulating factor use ...... o were receiving chemotherapy.
@en
P2093
Cara McDermott
David K Blough
Jennifer Malin
Lauren Clarke
Scott Ramsey
Sean D Sullivan
P2860
P356
10.1002/PHAR.1008
P407
P577
2012-01-01T00:00:00Z